Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2002;8(2):76–85. doi: 10.1080/13550280290049534

Murine hepatitis virus—A model for virus-induced CNS demyelination

A E Matthews 1, S R Weiss 1, Y Paterson 1,2,✉
PMCID: PMC7095071  PMID: 11935460

Abstract

Most murine hepatitis virus (MHV) strains, as their name suggests, infect the liver. However, several murine strains are tropic for the central nervous system (CNS) and cause encephalitis with subsequent CNS demyelination. The CNS demyelination shares pathological similarities with human CNS demyelinating diseases such as multiple sclerosis (MS). These viruses are, therefore, used to study the role of the immune system in viral clearance from the CNS, in CNS demyelination, and in remyelination. Nevertheless, it is still unclear exactly how MHV induces demyelination and to what extent the immune system plays a role in this pathology. Here we review this field in the context of the immune response to MHV in the liver and the CNS focusing on studies that have been published in the past 5 years.

Keywords: murine hepatitis virus, demyelination, immune response, CNS, multiple sclerosis

References

  1. Barthold SW, Smith AL. Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice. Arch Virol. 1992;122:35–44. doi: 10.1007/BF01321116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergmann CC, Altaian JD, Hinton D, Stohlman SA. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol. 1999;163:3379–3387. [PubMed] [Google Scholar]
  3. Bergmann CC, Ramakrishna C, Kornacki M, Stohlman SA. Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection. J Immunol. 2001;167:1575–1583. doi: 10.4049/jimmunol.167.3.1575. [DOI] [PubMed] [Google Scholar]
  4. Brabb T, von Dassow P, Ordonez N, Schnabel B, Duke B, Goverman J. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J Exp Med. 2000;192:871–880. doi: 10.1084/jem.192.6.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Braun JS, Kaissling B, Le Hir M, Zenker W. Cellular components of the immune barrier in the spinal meninges and dorsal root ganglia of the normal rat: Immunohistochemical (MHC class II) and electron-microscopic observations. Cell Tissue Res. 1993;273:209–217. doi: 10.1007/BF00312822. [DOI] [PubMed] [Google Scholar]
  6. Brehm U, Piddlesden SJ, Gardinier MV, Linington C. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligo-dendrocyte glycoprotein (MOG) J Neuroimmunol. 1999;97:9–15. doi: 10.1016/S0165-5728(99)00010-7. [DOI] [PubMed] [Google Scholar]
  7. Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984;132:261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Coutelier JP, Godfraind C, Dveksler GS, Wysocka M, Cardellichio CB, Noel H, Holmes KV. B lymphocyte and macrophage expression of carcinoembryonic antigen-related adhesion molecules that serve as receptors for murine coronavirus. Eur J Immunol. 1994;24:1383–1390. doi: 10.1002/eji.1830240622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coutelier JP, van der Logt JT, Heessen FW, Warmer G, Van Snick J. IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med. 1987;165:64–69. doi: 10.1084/jem.165.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cserr HF, DePasquale M, Harling-Berg CJ, Park JT, Knopf PM. Afferent and efferent arms of the humoral immune response to CSF-administered albumins in a rat model with normal blood-brain barrier permeability. J Neuroimmunol. 1992;41:195–202. doi: 10.1016/0165-5728(92)90070-2. [DOI] [PubMed] [Google Scholar]
  11. Das Sarma J, Fu L, Tsai JC, Weiss SR, Lavi E. Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol. 2000;74:9206–9213. doi: 10.1128/JVI.74.19.9206-9213.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Even C, Rowland RR, Plagemann PG. Mouse hepatitis virus infection of mice causes long-term depletion of lactate dehydrogenase-elevating virus-permissive macrophages and T lymphocyte alterations. Virus Res. 1995;39:355–364. doi: 10.1016/0168-1702(95)00092-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA. Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 1989;168:162–167. doi: 10.1016/0042-6822(89)90415-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Genain CP, Cannella B, Hauser S, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med. 1999;5:170–175. doi: 10.1038/5532. [DOI] [PubMed] [Google Scholar]
  15. Godfraind C, Friedrich VL, Holmes KV, Dubois-Dalcq M. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol. 1989;109:2405–2416. doi: 10.1083/jcb.109.5.2405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Godfraind C, Holmes KV, Coutelier JP. Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice. J Virol. 1995;69:6541–6547. doi: 10.1128/jvi.69.10.6541-6547.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gombold JL, Sutherland RM, Lavi E, Paterson Y, Weiss SR. Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microb Pathog. 1995;18:211–221. doi: 10.1016/S0882-4010(95)90058-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gordon LB, Nolan SC, Ksander BR, Knopf PM, Harling-Berg CJ. Normal cerebrospinal fluid suppresses the in vitro development of cytotoxic T cells: Role of the brain microenvironment in CNS immune regulation. J Neuroimmunol. 1998;88:77–84. doi: 10.1016/S0165-5728(98)00077-0. [DOI] [PubMed] [Google Scholar]
  19. Herndon RM, Griffin DE, McCormick U, Weiner LP. Mouse hepatitis virus-induced recurrent demyelination. A preliminary report. Arch Neurol. 1975;32:32–35. doi: 10.1001/archneur.1975.00490430054008. [DOI] [PubMed] [Google Scholar]
  20. Herndon RM, Price DL, Weiner LP. Regeneration of oligodendroglia during recovery from demyelinating disease. Science. 1977;195:693–694. doi: 10.1126/science.190678. [DOI] [PubMed] [Google Scholar]
  21. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 1988;239:290–292. doi: 10.1126/science.3276004. [DOI] [PubMed] [Google Scholar]
  22. Holmes KV, Lai MCC. Coronaviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott-Raven; 1996. pp. 1075–1093. [Google Scholar]
  23. Hooper DC, Kean RB, Scott GS, Spitsin SV, Mikheeva T, Morimoto K, Bette M, Rohrenbeck AM, Dietzschold B, Weihe E. The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol. 2001;167:3470–3477. doi: 10.4049/jimmunol.167.6.3470. [DOI] [PubMed] [Google Scholar]
  24. Horwitz MS, Evans CF, Klier FG, Oldstone MB. Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the central nervous system: Astrocytes fail to express major histocompatibility complex class I and II molecules. Lab Invest. 1999;79:235–242. [PubMed] [Google Scholar]
  25. Houtman JJ, Fleming JO. Dissociation of demyelination and viral clearance in congenitally immuno-deficient mice infected with murine coronavirus JHM. J NeuroVirol. 1996;2:101–110. doi: 10.3109/13550289609146543. [DOI] [PubMed] [Google Scholar]
  26. Huitinga I, Ruuls SR, Jung S, Van Rooijen N, Hartung HP, Dijkstra CD. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin Exp Immunol. 1995;100:344–351. doi: 10.1111/j.1365-2249.1995.tb03675.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Irani DN, Lin KI, Griffin DE. Regulation of brain-derived T cells during acute central nervous system inflammation. J Immunol. 1997;158:2318–2326. [PubMed] [Google Scholar]
  28. Joseph J, Kim R, Siebert K, Lublin FD, Offenbach C, Knobler RL. Organ specific endothelial cell heterogeneity influences differential replication and cytopathogenicity of MHV-3 and MHV-4. Implications in viral tropism. Adv Exp Med Biol. 1995;380:43–50. doi: 10.1007/978-1-4615-1899-0_6. [DOI] [PubMed] [Google Scholar]
  29. Kajino K, Kajino Y, Greene MI. Fas- and perforin-independent mechanisms of cytotoxic T lymphocyte. Immunol Res. 1998;17:89–93. doi: 10.1007/BF02786434. [DOI] [PubMed] [Google Scholar]
  30. Knobler RL, Lampert PW, Oldstone MB. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature. 1982;298:279–280. doi: 10.1038/298279a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Knobler RL, Oldstone MB. Infection and involution of mouse thymus by MHV-4. Adv Exp Med Biol. 1987;218:451–453. doi: 10.1007/978-1-4684-1280-2_56. [DOI] [PubMed] [Google Scholar]
  32. Koolen MJ, Love S, Wouda W, Calafat J, Horzinek MC, van der Zeijst BA. Induction of demyelination by a temperature-sensitive mutant of the coronavirus MHV-A59 is associated with restriction of viral replication in the brain. J Gen Virol. 1987;68:703–714. doi: 10.1099/0022-1317-68-3-703. [DOI] [PubMed] [Google Scholar]
  33. Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA. 1993;90:3024–3027. doi: 10.1073/pnas.90.7.3024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Korner H, Schliephake A, Winter J, Zimprich F, Lassmann H, Sedgwick J, Siddell S, Wege H. Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells. J Immunol. 1991;147:2317–2323. [PubMed] [Google Scholar]
  35. Kristensson K, Norrby E. Persistence of RNA viruses in the central nervous system. Annu Rev Microbiol. 1986;40:159–184. doi: 10.1146/annurev.mi.40.100186.001111. [DOI] [PubMed] [Google Scholar]
  36. Kyuwa S, Machii K, Shibata S. Role of CD4+ and CD8+ T cells in mouse hepatitis virus infection in mice. Exp Anim. 1996;45:81–83. doi: 10.1538/expanim.45.81. [DOI] [PubMed] [Google Scholar]
  37. Lampert PW. Autoimmune and virus induced demyelinating diseases. A review. Am J Pathol. 1978;91:176–208. [PMC free article] [PubMed] [Google Scholar]
  38. Lampert PW, Sims JK, Kniazeff AJ. Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol (Berl) 1973;24:76–85. doi: 10.1007/BF00691421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ. Dynamic regulation of α- and β-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol. 1998;160:970–978. [PubMed] [Google Scholar]
  40. Lane TE, Buchmeier MJ. Inhibition of nitric oxide synthase-2 reduces the severity of mouse hepatitis virus-induced demyelination: Implications for NOS2/NO regulation of chemokine expression and inflammation. J NeuroVirol. 1999;5:48–54. doi: 10.3109/13550289909029745. [DOI] [PubMed] [Google Scholar]
  41. Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ. A central role for CD4+ T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol. 2000;74:1415–1424. doi: 10.1128/JVI.74.3.1415-1424.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Lane TE, Paoletti AD, Buchmeier MJ. Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J Virol. 1997;71:2202–2210. doi: 10.1128/jvi.71.3.2202-2210.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Lardans V, Godfraind C, van der Logt JT, Heessen WA, Gonzalez MD, Coutelier JP. Polyclonal B lymphocyte activation induced by mouse hepatitis virus A59 infection. J Gen Virol. 1996;77:1005–1009. doi: 10.1099/0022-1317-77-5-1005. [DOI] [PubMed] [Google Scholar]
  44. Lavi E, Das Sarma J, Weiss SR. Cellular reservoirs for coronavirus infection of the brain in beta2-microglobulin knockout mice. Pathobiology. 1999;67:75–83. doi: 10.1159/000028054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lavi E, Gilden DH, Highkin MK, Weiss SR. Detection of MHV-A59 RNA by in situ hybridization. Adv Exp Med Biol. 1984;173:247–257. doi: 10.1007/978-1-4615-9373-7_25. [DOI] [PubMed] [Google Scholar]
  46. Lavi E, Gilden DH, Highkin MK, Weiss SR. The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab Anim Sci. 1986;36:130–135. [PubMed] [Google Scholar]
  47. Lavi E, Gilden DH, Wroblewska Z, Rorke RB, Weiss SR. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology. 1984;34:597–603. doi: 10.1212/wnl.34.5.597. [DOI] [PubMed] [Google Scholar]
  48. Lavi E, Murray EM, Makino S, Stohlman SA, Lai MM, Weiss SR. Determinants of coronavirus MHV pathogenesis are localized to 3′ portions of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab Invest. 1990;62:570–578. [PubMed] [Google Scholar]
  49. Lavi E, Suzumura A, Hirayama M, Highkin MK, Dambach DM, Silberberg DH, Weiss SR. Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb Pathog. 1987;3:79–86. doi: 10.1016/0882-4010(87)90066-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, Weiss SR. Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol. 1998;72:9628–9636. doi: 10.1128/jvi.72.12.9628-9636.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Lin MT, Hinton DR, Marten NW, Bergmann CC, Stohlman SA. Antibody prevents virus reactivation within the central nervous system. J Immunol. 1999;162:7358–7368. [PubMed] [Google Scholar]
  52. Lin MT, Hinton DR, Parra B, Stohlman SA, van der Veen RC. The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology. 1998;245:270–280. doi: 10.1006/viro.1998.9170. [DOI] [PubMed] [Google Scholar]
  53. Lin MT, Stohlman SA, Hinton DR. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol. 1997;71:383–391. doi: 10.1128/jvi.71.1.383-391.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Lin RF, Lin T-S, Tilton RG. Nitric oxide localized in the spinal cords of mice with experimental allergic encephalomyelitis: An electroparamagnetic study. J Exp Med. 1993;178:643–648. doi: 10.1084/jem.178.2.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Lipton HL, Gonzalez-Scarano F. Central nervous system immunity in mice infected with Theiler’s virus. I. Local neutralizing antibody response. J Infect Dis. 1978;137:145–151. doi: 10.1093/infdis/137.2.145. [DOI] [PubMed] [Google Scholar]
  56. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE. Cutting edge: The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol. 2000;165:2327–2330. doi: 10.4049/jimmunol.165.5.2327. [DOI] [PubMed] [Google Scholar]
  57. Marten NW, Stohlman SA, Atkinson RD, Hinton DR, Fleming JO, Bergmann CC. Contributions of CD8+ T cells and viral spread to demyelinating disease. J Immunol. 2000;164:4080–4088. doi: 10.4049/jimmunol.164.8.4080. [DOI] [PubMed] [Google Scholar]
  58. Matthews AE, Lavi E, Weiss SR, Paterson Y (2002). Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. J NeuroVirol, in press. [DOI] [PMC free article] [PubMed]
  59. Matthews AE, Weiss SR, Shlomchik M, Hannum LG, Gombold JL, Paterson Y (2001). Antibody is required for clearance of infectious murine hepatitis virus A59 from the CNS but not the liver. J Immunol, in press. [DOI] [PubMed]
  60. Murray RS, Cai GY, Hoel K, Zhang JY, Soike KF, Cabirac GF. Coronavirus infects and causes demyelination in primate central nervous system. Virology. 1992;188:274–284. doi: 10.1016/0042-6822(92)90757-G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Navas S, Seo SH, Chua MM, Sarma JD, Lavi E, Hingley ST, Weiss SR. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. J Virol. 2001;75:2452–2457. doi: 10.1128/JVI.75.5.2452-2457.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Pachuk CJ, Bredenbeek PJ, Zoltick PW, Spaan WJ, Weiss SR. Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59. Virology. 1989;171:141–148. doi: 10.1016/0042-6822(89)90520-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Parra B, Hinton DR, Lin MT, Cua DJ, Stohlman SA. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology. 1997;233:260–270. doi: 10.1006/viro.1997.8613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA. IFN-gamma is required for viral clearance from central nervous system oligo-dendroglia. J Immunol. 1999;162:1641–1647. [PubMed] [Google Scholar]
  65. Parra, Lin MT, Stohlman SA, Bergmann CC, Atkinson R, Hinton DR. Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system. J Virol. 2000;74:2447–2450. doi: 10.1128/JVI.74.5.2447-2450.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Perlman S, Jacobsen G, Afifi A. Spread of a neurotropic murine coronavirus into the CNS via the trigeminal and olfactory nerves. Virology. 1989;170:556–560. doi: 10.1016/0042-6822(89)90446-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Perlman S, Ries D. The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb Pathog. 1987;3:309–314. doi: 10.1016/0882-4010(87)90064-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Phillips JJ, Chua MM, Lavi E, Weiss SR. Pathogenesis of chimeric MHV-4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. J Virol. 1999;73:7752–7760. doi: 10.1128/jvi.73.9.7752-7760.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Powell HC, Lampert PW. Oligodendrocytes and their myelin-plasma membrane connections in JHM mouse hepatitis virus encephalomyelitis. Lab Invest. 1975;33:440–445. [PubMed] [Google Scholar]
  70. Rossi CP, Delcroix M, Huitinga I, McAllister A, van Rooijen N, Claassen E, Brahic M. Role of macrophages during Theiler’s virus infection. J Virol. 1997;71:3336–3340. doi: 10.1128/jvi.71.4.3336-3340.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Schijns VE, Wierda CM, van Hoeij M, Horzinek MC. Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12. J Immunol. 1996;157:815–821. [PubMed] [Google Scholar]
  72. Schwender S, Hein A, Imrich H, Czub S, Dorries R. Modulation of acute coronavirus-induced encephalomyelitis in gamma-irradiated rats by transfer of naïve lymphocyte subsets before infection. J NeuroVirol. 1999;5:249–257. doi: 10.3109/13550289909015811. [DOI] [PubMed] [Google Scholar]
  73. Stevenson PG, Freeman S, Bangham CR, Hawke S. Virus dissemination through the brain parenchyma without immunologic control. J Immunol. 1997;159:1876–1884. [PubMed] [Google Scholar]
  74. Stohlman SA, Bergmann CC, Cua DJ, Lin MT, Ho S, Wei W, Hinton DR. Apoptosis of JHMV-specific CTL in the CNS in the absence of CD4+ T cells. Adv Exp Med Biol. 1998;440:425–430. doi: 10.1007/978-1-4615-5331-1_53. [DOI] [PubMed] [Google Scholar]
  75. Stohlman SA, Bergmann CC, Lin MT, Cua DJ, Hinton DR. CTL effector function within the central nervous system requires CD4[+ T cells. J Immunol. 1998;160:2896–2904. [PubMed] [Google Scholar]
  76. Stohlman SA, Bergmann CC, van der Veen RC, Hinton DR. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J Virol. 1995;69:684–694. doi: 10.1128/jvi.69.2.684-694.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Stohlman SA, Hinton DR, Cua D, Dimacali E, Sensintaffar J, Hofman FM, Tahara SM, Yao Q. Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. J Virol. 1995;69:5898–5903. doi: 10.1128/jvi.69.9.5898-5903.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Stohlman SA, Matsushima GK, Casteel N, Weiner LP. In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J Immunol. 1986;136:3052–3056. [PubMed] [Google Scholar]
  79. Stohlman SA, Weiner LP. Chronic central nervous system demyelination in mice after JHM virus infection. Neurology. 1981;31:38–44. doi: 10.1212/wnl.31.1.38. [DOI] [PubMed] [Google Scholar]
  80. Sun N, Grzybicki D, Castro RF, Murphy S, Perlman S. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology. 1995;213:482–493. doi: 10.1006/viro.1995.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Sun N, Perlman S. Spread of a neurotropic corona-virus to spinal cord white matter via neurons and astrocytes. J Virol. 1995;69:633–641. doi: 10.1128/jvi.69.2.633-641.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Sutherland RM, Chua MM, Lavi E, Weiss SR, Paterson Y. CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J NeuroVirol. 1997;3:225–228. doi: 10.3109/13550289709018297. [DOI] [PubMed] [Google Scholar]
  83. Suzumura A, Lavi E, Weiss SR, Silberberg DH. Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science. 1986;232:991–993. doi: 10.1126/science.3010460. [DOI] [PubMed] [Google Scholar]
  84. Takahashi K, Goto N, Matsubara Y, Fujiwara K. Post inflammatory remyelination in the spinal cord of mice infected with mouse hepatitis virus, JHM strain. Jpn J Exp Med. 1987;57:145–151. [PubMed] [Google Scholar]
  85. Wang FI, Hinton DR, Gilmore W, Trousdale MD, Fleming JO. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest. 1992;66:744–754. [PubMed] [Google Scholar]
  86. Wang Q, Haluskey JA, Lavi E. Coronavirus MHV-A59 causes upregulation of interferon-beta RNA in primary glial cell cultures. Adv Exper Med Biol. 1998;440:451–454. doi: 10.1007/978-1-4615-5331-1_57. [DOI] [PubMed] [Google Scholar]
  87. Weiner LP. Pathogenesis of demyelination induced by a mouse hepatitis. Arch Neurol. 1973;28:298–303. doi: 10.1001/archneur.1973.00490230034003. [DOI] [PubMed] [Google Scholar]
  88. Wijburg OL, Heemskerk MH, Boog CJ, Van Rooijen N. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59. Immunology. 1997;92:252–258. doi: 10.1046/j.1365-2567.1997.00340.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Wijburg OL, Heemskerk MH, Sanders A, Boog CJ, Van Rooijen N. Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection. Immunology. 1996;87:34–41. [PMC free article] [PubMed] [Google Scholar]
  90. Williams RK, Jiang GS, Holmes KV. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci USA. 1991;88:5533–5536. doi: 10.1073/pnas.88.13.5533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Williamson JSP, Stohlman SA. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol. 1990;64:4589–4592. doi: 10.1128/jvi.64.9.4589-4592.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Williamson JSP, Sykes KC, Stohlman SA. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J Neuroimmunol. 1991;32:199–207. doi: 10.1016/0165-5728(91)90189-E. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Wu GF, Dandekar AA, Pewe L, Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol. 2000;165:2278–2286. doi: 10.4049/jimmunol.165.4.2278. [DOI] [PubMed] [Google Scholar]
  94. Wu GF, Perlman S. Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol. 1999;73:8771–8780. doi: 10.1128/jvi.73.10.8771-8780.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Xue S, Sun N, Van Rooijen N, Perlman S. Depletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus. J Virol. 1999;73:6327–6334. doi: 10.1128/jvi.73.8.6327-6334.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Yokomori K, Baker SC, Stohlman SA, Lai MM. Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. J Virol. 1992;66:2865–2874. doi: 10.1128/jvi.66.5.2865-2874.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurovirology are provided here courtesy of Nature Publishing Group

RESOURCES

OSZAR »